Zobrazeno 1 - 10
of 61
pro vyhledávání: '"J.M. Sanchez Torres"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G. Ruiz de Garibay, B. Roch, P. Garrido Lopez, D. Isla, C. Aguado, A. Callejo Perez, R. Marse Fabregat, M.R. Garcia Campelo, A. Blasco Cordellat, J.M. Sanchez Torres, R. Bernabe Caro, O.J. Juan Vidal, J. De Castro Carpeno, F.F. Franco, I. Ramos Garcia, A. Gomez Rueda, E. Conde Gallego, S. Ponce Aix, L. Paz-Ares, J. Zugazagoitia
Publikováno v:
Annals of Oncology. 33:S1015-S1016
Autor:
B. Rubio-Viqueira, C. Gonzalez Arenas, J.M. Sanchez Torres, J.J. Garcia Gonzalez, J.F. Cordoba-Ortega, I. Maestu Maiques, M. Lázaro, J. Valdivia-Bautista, A. Blasco Cordellat, S. Vazquez Estevez, M. Majem Tarruella
Publikováno v:
Annals of Oncology. 31:S1437-S1438
Autor:
Sandra Falagan, A. Lopez Martin, R. Lopez Castro, S. Cerezo Gonzalez, Ricard Cervera, L. Cabezón Gutiérrez, E. Pérez Fernández, Pedro Mateos Cruz, A. Gómez Rueda, Jazmina Núñez, A. Calles Blanco, J.M. Sanchez Torres, M. Sotelo Lezama, A.M. Sánchez Peña, X. Mielgo Rubio, E. Martinez Moreno, M. Antoñanzas, C. Pangua Mendez, I. Gómez-Barreda, B. Jimenez Munarriz
Publikováno v:
Annals of Oncology. 30:v619-v620
Background Derived neutrophils/(leukocytes-neutrophils) ratio (dNLR) and lactate dehydrogenase (LDH) level have been correlated with immune checkpoint inhibitors (ICI) outcomes. A lung immune prognostic index (LIPI) that showed association with ICI o
Autor:
Emilio Esteban, M.D. Isla Casado, I.C. Barneto Aranda, Angel Artal-Cortes, Ma.Teresa Alvarez y Muñoz, José Sánchez-Payá, J.M. Sanchez Torres, Jose-Luis Gonzalez-Larriba, M. Provencio, D. Rodriguez Abreu, J. De Castro Carpeno, Rosa Rosell, E. Pereira, M.T. Moran Bueno, B. Massuti Sureda, L. Iglesias, G. López Vivanco, M. Cobo Dols, R. López, R. de las Penas Bataller
Publikováno v:
Annals of Oncology. 30:v585
Background Post-operative platinum-based chemotherapy is the standard of care for resected NSCLC with nodal involvement. Expression of genes involved in DNA repair may have a prognostic role for the outcome. BRCA1 plays an important role in DNA repai
Autor:
Julia Calzas, M. Majem Tarruella, A. Paredes Lario, M. Sereno Moyano, E. Nogueron Martnez, L. Capdevila Riera, J.A. Campillo Fuentes, M. Cobo Dols, B. Rubio-Viqueira, M. Provencio, M. Guillot Morales, R. Lopez Castro, J. Valdivia-Bautista, Pilar Lianes, M. Martínez, M.A. Muñoz, X. Mielgo Rubio, O.J. Juan Vidal, J.M. Sanchez Torres, P. Diz Tain
Publikováno v:
Annals of Oncology. 30:v750
Background Lung cancer is the leading cause of cancer mortality worldwide with more than 2 million new cases and 1.8 million deaths in 2018. The TTR could be of use to objectively understand the clinical reality of lung cancer in Spain. Methods Obser
Autor:
Antonio Garrido, Jacobo Rogado, J Serra, Pedro Gullón, R. Colomer Bosch, Pablo Costas, N. Romero Laorden, O. Donnay, Javier Aspa, R. Mondejar, A.I. Ballesteros Garcia, Magdalena Adrados, A. Lorenzo, J.M. Sanchez Torres, V. Pacheco-Barcia, Reyes Arranz, Ana M. Ramos-Leví, Arantzazu Alfranca
Publikováno v:
Annals of Oncology. 30:v523
Background Immunotherapy is a new and effective form of therapy in several types of cancer, although molecular predictors of response are limited. Recently, we have described that immune-related adverse-events (irAEs) are significantly associated wit
Autor:
L. Fernandez-Fornos, M.A. Sala, S. Vazquez Estevez, Jose-Luis Gonzalez-Larriba, J. Coves Sarto, B. Massuti Sureda, A. Paredes Lario, M.D. Isla Casado, M. Domine Gomez, David Vicente, Margarita Majem, R. Marse Fabregat, A.L. Ortega Granados, F. Varcarcel, R. de las Penas Bataller, M. Provencio, J.M. Sanchez Torres, N. Farre Bernado, M. Guirado, M.T. Moran Bueno
Publikováno v:
Annals of Oncology. 30:v594
Background CT-RT is the standard treatment for unresectable LA-NSCLC. P plus vinorelbine is widely used. Metronomic CT is a frequent administration of low doses of CT. mOV has shown good efficacy and improved safety, and could improve the RT effect.
Autor:
Jazmina Núñez, R Alvarez Cabellos, X. Mielgo Rubio, Ricard Cervera, M. Domine Gomez, A. Calles Blanco, S. Cerezo Gonzalez, Pedro Mateos Cruz, R. Lopez Castro, A. Velastegui Ordoñez, I. Nalda Ariza, C. Pangua Mendez, M.E. Olmedo García, M. Sereno Moyano, L. Cabezón Gutiérrez, A.M. Sánchez Peña, A. Lopez Martin, Cristina Aguado, J.M. Sanchez Torres, E. Pérez Fernández
Publikováno v:
Annals of Oncology. 30:v514
Background Pembrolizumab monotherapy improved overall survival (OS), progression free survival (PFS) and response rate compared to chemotherapy in patients with treatment-naive advanced NSCLC with high PD-L1 expression ( > =50%), but we see in daily
Autor:
Jacobo Rogado, R. Mondéjar Solís, A.I. Ballesteros Garcia, A. Lorenzo, Reyes Arranz, N. Romero Laorden, V. Pacheco-Barcia, R. Colomer Bosch, Pedro Gullón, J.M. Sanchez Torres
Publikováno v:
Annals of Oncology. 29:viii435